Loading
Dozens of rice-grain-sized radioactive seeds are implanted permanently in the prostate in a single procedure and deliver their dose over months.
Permanent seed implantation uses iodine-125 or palladium-103 seeds placed through the perineum under ultrasound guidance in a one-off outpatient procedure. It is a curative option for low- and favourable intermediate-risk prostate cancer with control matching surgery and external radiotherapy, and is used as a boost in higher-risk disease (the ASCENDE-RT trial). The same seeds treat some lung and pancreatic tumours at surgery, and plaque brachytherapy with similar isotopes treats uveal melanoma.
Permanently implanted low-activity sources deliver a continuous low dose rate over weeks to months, exploiting repair differences between tumour and normal tissue.
Query for this technology: (TITLE:"Low-dose-rate seed brachytherapy" OR ABSTRACT:"Low-dose-rate seed brachytherapy") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Low-dose-rate seed brachytherapy, not a curated reading list.
Shares Brachytherapy (internal radiotherapy), Remote afterloaders for HDR brachytherapy, Brachytherapy, Prostate cancer and the tag radiation-wave1.
Shares Remote afterloaders for HDR brachytherapy and the tag radiation-wave1.
Shares Prostate cancer and the tag radiation-wave1.
Shares Prostate cancer and the tag radiation-wave1.
Shares Prostate cancer and the tag radiation-wave1.
Shares Remote afterloaders for HDR brachytherapy, Brachytherapy.
Shares Uveal melanoma, Prostate cancer.
Shares Brachytherapy, Prostate cancer.